December 13, 2017 | News Release Review 1

Marijuana may slow mental decline ‘in up to 50 percent of HIV patients’? Bold claim unsupported by research

Pot for thought? How about a better explanation of the science before we send HIV patients to the green pharmacy.

1 Star

Marijuana May Help HIV Patients Keep Mental Stamina Longer

December 12, 2017 | Story Review

Gene therapy and hemophilia: Washington Post wisely tells readers ‘the study has some limitations’

Whether this particular treatment revolutionizes the landscape for hemophilia B sufferers will remain an open question for some years–and the story should have emphasized that more.

4 Star

Gene therapy makes a big advance treating hemophilia B blood disorder

December 11, 2017 | News Release Review

Kerastem gives thin summary of phase 2 hair growth procedure results

Readers aren’t even told if the procedure will be available in the US.

2 Star

Kerastem Reports Successful US Phase II Hair Growth Clinical Trial Results

December 11, 2017 | Story Review

A short, small study can’t prove opening doors or windows improves sleep quality

3 Star

Open windows and doors can improve sleep quality

December 8, 2017 | News Release Review

Newcastle U’s second take on type 2 diabetes research still comes up short

The more recent release does a better job of addressing benefits and the quality of the evidence.

2 Star

Type 2 diabetes is not for life

December 7, 2017 | Story Review

When weight loss is the intervention, it’s still important to talk about costs and harms

To its credit, the story competently describes the study methods and findings.

3 Star

Weight Loss Really Can Reverse Diabetes, New Study Finds

December 6, 2017 | Story Review

Outside experts help round out NBC’s report on minimally invasive back pain procedure

However, the headline’s a bit more positive than perhaps it should be, and information about financial costs and potential harms is missing,

3 Star

Radiofrequency therapy relieved herniated disc pain in new study

December 5, 2017 | Story Review

Guardian story on new migraine drug never establishes why it’s ‘an important step forward’

But, the piece does a good job putting the results into context and even compares those findings to the placebo group, giving them a more transparent and helpful context.

2 Star

Migraine drug could halve the length of attacks, study shows

Toolkit

Tips for Understanding Studies

View More

Toolkit

Story Reviews

Our team of reviewers applies 10 standardized criteria to news stories that include claims about health care interventions. ~2,000 reviews published.

Read More

News Release Reviews

We systematically evaluate the quality of health care-related news releases by journals, medical centers, drug/device makers, others.

Read More

Blog

Wide-ranging exploration of issues in journalism, journal publishing, health care PR, advertising and marketing. Some opinions - publisher Gary Schwitzer's & others'.

Read More